Article
Cost-effectiveness of partially-hydrolyzed formula for prevention of atopic dermatitis in Australia.
Journal of medical economics - 1 Jan 2012
Su John, Prescott Susan, Sinn John, Tang Mimi, Smith Peter, Heine Ralf G, Spieldenner Jörg, Iskedjian Michael
Abstract excerpt
OBJECTIVE: To perform an economic evaluation of a specific brand of partially hydrolyzed infant formula (PHF-W) in the prevention of atopic dermatitis (AD) among Australian infants. METHODS: A cost-effectiveness analysis was undertaken from the perspectives of the Department of Health and Aging (...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
